Document:

Form of indemnification agreement between the Registrant and its directors

 Exhibit 10.47 
 INDEMNIFICATION AGREEMENT 
 THIS INDEMNIFICATION AGREEMENT (this
“Agreement”) is made and entered into this      day of                     ,
20    , by and between Rib-X Pharmaceuticals, Inc., a Delaware corporation (the “Corporation”), and
                     (“Agent”). 
 RECITALS 
 WHEREAS, Agent performs a valuable service to the
Corporation in Agent’s capacity as [a director and/or an officer] of the Corporation; 
 WHEREAS, the Corporation
has adopted provisions providing for indemnification of directors and officers included in its Restated Certificate of Incorporation (the “Charter”) and its bylaws (the “Bylaws”) providing for the
indemnification of the directors, officers, employees and other agents of the Corporation, including persons serving at the request of the Corporation in such capacities with other corporations or enterprises, as authorized by the Delaware General
Corporation Law, as amended (the “DGCL”); 
 WHEREAS, the Charter, the Bylaws and the DGCL, by
their non-exclusive nature, permit contracts between the Corporation and its directors, officers, employees and other agents with respect to indemnification of such persons; 
 WHEREAS, in recognition of Agent’s need for (a) substantial protection against personal liability based on Agent’s reliance on the Charter and the Bylaws, and (b) specific
contractual assurance that the protection provided in the Charter and the Bylaws will be available to Agent (regardless of, among other things, any amendment to or revocation of the Charter and/or the Bylaws, any change in the composition of the
Corporation’s board of directors or a change in control of the Corporation); and 
 WHEREAS, in order to induce
Agent to [continue to] serve as [a director/an officer] of the Corporation, the Corporation has determined and agreed to enter into this Agreement with Agent. 
 NOW, THEREFORE, in consideration of Agent’s service as [a director and/or an officer] of the Corporation following the date hereof, and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the Corporation and Agent hereby agree as follows: 
 1. Services to the
Corporation. Agent will serve, at the will of the Corporation or under separate contract, if any such contract exists, as [a director/an officer] of the Corporation or as a director, officer or other fiduciary of an affiliate of the Corporation
(including any employee benefit plan of the Corporation) faithfully and to the best of Agent’s ability so long as Agent [is duly elected and qualified in accordance with the provisions of the Bylaws or other applicable charter documents/is a
duly appointed officer] of the Corporation or such affiliate; provided, however, that Agent may at any time and for any reason resign from such position (subject to any contractual obligation that Agent may have assumed apart from this
Agreement) and that the Corporation or any affiliate shall have no obligation under this Agreement to continue Agent in any such position. 
 2. Indemnity of Agent. The Corporation agrees to hold harmless and indemnify Agent to the fullest extent authorized or permitted by the provisions of the Charter, the Bylaws and the

 
DGCL, as the same may be amended from time to time (but, only to the extent that such amendment permits the Corporation to provide broader indemnification rights than the Charter, the Bylaws or
the DGCL permitted prior to adoption of such amendment). 
 3. Additional Indemnity. In addition to and not in limitation
of the indemnification otherwise provided for herein, and subject only to the exclusions set forth in Section 4 hereof, the Corporation further agrees to hold harmless and indemnify Agent: 

(a) against any and all expenses (including attorneys’ fees), witness fees, damages, judgments, fines and amounts paid in
settlement and any other amounts that Agent becomes legally obligated to pay (including any federal, state or local taxes imposed on Agent as a result of receipt of reimbursements or advances of expenses under this Agreement) because of any claim or
claims made against or by him in connection with any threatened, pending or completed action, suit or proceeding, including any appeal and the premium, security for, and other costs relating to any costs bond, supersedes bond, or other appeal bond
or its equivalent, whether civil, criminal, arbitrational, administrative or investigative, whether formal or informal (including an action by or in the right of the Corporation), to which Agent is, was or at any time becomes a party or a witness,
or is threatened to be made a party or a witness, by reason of the fact that Agent is, was or at any time becomes a director, officer, employee or other agent of the Corporation, or is or was serving or at any time serves at the request of the
Corporation as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise; and 
 (b) otherwise to the fullest extent as may be provided to Agent by the Corporation under the non-exclusivity provisions of the DGCL, the Charter and the Bylaws. 

4. Limitations on Additional Indemnity. No indemnity pursuant to Section 3 hereof shall be paid by the Corporation:

 (a) on account of any claim or proceeding against Agent for an accounting of profits made from the purchase or sale by
Agent of securities of the Corporation pursuant to the provisions of Section 16(b) of the Securities Exchange Act of 1934, as heretofore or hereafter amended (the “Exchange Act”), or similar provisions of any federal,
state or local law, provided, however, if and when Agent ultimately establishes in any such proceeding that no recovery of profits from Agent is permitted under Section 16(b) of the Exchange Act or such similar provision of any similar
federal, state or local law, then, notwithstanding anything to the contrary provided in this Section 4(a), indemnification pursuant to this Agreement shall then be permitted; 

(b) on account of Agent’s conduct that is established by a final judgment as knowingly fraudulent or deliberately dishonest
or that constituted willful misconduct; 
 (c) on account of Agent’s conduct that is established by a final judgment
as constituting a breach of Agent’s duty of loyalty to the Corporation or resulting in any personal profit or advantage to which Agent was not legally entitled; 
 (d) for which payment is actually made to Agent under a valid and collectible insurance policy or under a valid and enforceable indemnity clause, bylaw or agreement, except in respect of any excess
beyond payment under such insurance, clause, bylaw or agreement; 

  
 2 

 (e) if indemnification is not lawful (and, in this respect, both the Corporation and
Agent have been advised that the Securities and Exchange Commission believes that indemnification for liabilities arising under the federal securities laws is against public policy and is, therefore, unenforceable and that claims for indemnification
should be submitted to appropriate courts for adjudication); or 
 (f) in connection with any proceeding (or part
thereof) initiated by Agent, or any proceeding by Agent against the Corporation or its directors, officers, employees or other agents, unless (i) such indemnification is expressly required to be made by law, (ii) the proceeding was
authorized by the board of directors of the Corporation, (iii) such indemnification is provided by the Corporation, in its sole discretion, pursuant to the powers vested in the Corporation under the DGCL, or (iv) the proceeding is
initiated pursuant to Section 11 hereof. 
 5. Continuation of Indemnity. All agreements and obligations of the
Corporation contained herein shall continue during the period Agent is a director, officer, employee or other agent of the Corporation (or is or was serving at the request of the Corporation as a director, officer, employee or other agent of another
corporation, partnership, joint venture, trust, employee benefit plan or other enterprise) and shall continue thereafter so long as Agent shall be subject to any possible claim or threatened, pending or completed action, suit or proceeding, whether
civil, criminal, arbitrational, administrative or investigative, by reason of the fact that Agent was serving in the capacity referred to herein. 
 6. Partial Indemnification. Agent shall be entitled under this Agreement to indemnification by the Corporation for a portion of the expenses (including attorneys’ fees), witness fees, damages,
judgments, fines and amounts paid in settlement and any other amounts that Agent becomes legally obligated to pay in connection with any action, suit or proceeding referred to in Section 3 hereof even if not entitled hereunder to
indemnification for the total amount thereof, and the Corporation shall indemnify Agent for the portion thereof to which Agent is entitled. 
 7. Notification and Defense of Claim. As soon as practicable, and in any event, not later than thirty (30) days after Agent becomes aware, by written or other overt communication, of any
pending or threatened litigation, claim or assessment, Agent will, if a claim in respect thereof is to be made against the Corporation under this Agreement, notify the Corporation of such pending or threatened litigation, claim or assessment; but
the omission so to notify the Corporation will not relieve it from any liability which it may have to Agent otherwise than under this Agreement. With respect to any such pending or threatened litigation, claim or assessment as to which Agent
notifies the Corporation of the commencement thereof: 
 (a) the Corporation will be entitled to participate therein at
its own expense; 
 (b) except as otherwise provided below, the Corporation may, at its option and jointly with any other
indemnifying party similarly notified and electing to assume such defense, assume the defense thereof, with counsel reasonably satisfactory to Agent. After notice from the Corporation to Agent of its election to assume the defense thereof, the
Corporation will not be liable to Agent under this Agreement for any legal or other expenses subsequently incurred by Agent in connection with the defense thereof except for reasonable costs of investigation or otherwise as provided below. Agent
shall have the right to employ separate counsel in such action, suit or proceeding but the fees and expenses of such counsel incurred after notice from the Corporation of its assumption of the defense thereof shall be at the expense of Agent unless
(i) the employment of 

  
 3 

 
counsel by Agent has been authorized by the Corporation, (ii) Agent shall have reasonably concluded, and so notified the Corporation, that there is an actual conflict of interest between the
Corporation and Agent in the conduct of the defense of such action, or (iii) the Corporation shall not in fact have employed counsel to assume the defense of Agent in connection with such action, in any of such cases the fees and expenses of
Agent’s separate counsel shall be at the expense of the Corporation. The Corporation shall not be entitled to assume the defense of any action, suit or proceeding brought by or on behalf of the Corporation or as to which Agent shall have made
the conclusion provided for in clause (ii) above; and 
 (c) the Corporation shall not be liable to indemnify Agent
under this Agreement for any amounts paid in settlement of any action or claim effected without its written consent, which shall not be unreasonably withheld or delayed. The Corporation shall be permitted to settle any action or claim except that it
shall not settle any action or claim in any manner which would impose any penalty or limitation on Agent without Agent’s written consent, which may be given or withheld in Agent’s sole discretion. 

8. Expenses. The Corporation shall advance, prior to the final disposition of any proceeding, promptly following request therefor,
all expenses incurred by Agent in connection with such proceeding upon the Corporation’s receipt of an undertaking by or on behalf of Agent to repay said amounts if it shall be determined ultimately that Agent is not entitled to be indemnified
under the provisions of this Agreement, the Charter, the Bylaws, the DGCL or otherwise. Such undertaking shall be accepted by the Corporation without regard to the financial ability of Agent to make such repayment. Without limiting the foregoing, if
any action, suit or proceeding is disposed of on the merits or otherwise (including a disposition without prejudice), without (i) the final disposition being adverse to Agent, (ii) a final adjudication that Agent was liable to the
Corporation, (iii) a plea of guilty (iv) a final adjudication that Agent did not act in good faith, and in a manner Agent reasonably believed to be in or not opposed to the best interests of the Corporation, or (v) with respect to any
criminal proceeding, a final adjudication that Agent had reasonable cause to believe Agent’s conduct was unlawful, Agent shall be considered for the purposes hereof to have been wholly successful with respect thereto. 

9. Information Sharing. To the extent that the Corporation receives a request or requests from a governmental third party or other
licensing or regulating organization (the “Requesting Agency”), whether formal or informal, to produce documentation or other information concerning an investigation, whether formal or informal, being conducted by the
Requesting Agency, and such investigation is reasonably likely to include review of any actions or failures to act by Agent, the Corporation shall promptly give notice to Agent of said request or requests and any subsequent request. In addition, the
Corporation shall provide Agent with a copy of any and all information or documentation that the Corporation shall provide to the Requesting Agency. 
 10. No Imputation. The knowledge and/or actions, or failure to act, of any director, officer, agent or employee of the Corporation or the Corporation itself shall not be imputed to Agent for
purposes of determining any rights under this Agreement. 
 11. Enforcement. Any right to indemnification or advances
granted by this Agreement to Agent shall be enforceable by or on behalf of Agent in any court of competent jurisdiction if (i) the claim for indemnification or advances is denied, in whole or in part, or (ii) no disposition of such claim
is made within ninety (90) days of request therefor. Agent, in such enforcement action, if successful in whole or in part, shall be entitled to be paid also the expense of prosecuting Agent’s

  
 4 

 
claim. It shall be a defense to any action for which a claim for indemnification is made under Section 3 hereof (other than an action brought to enforce a claim for advance or reimbursement
of expenses under this Agreement, provided that the required undertaking has been tendered to the Corporation) that Agent is not entitled to indemnification because of the limitations set forth in Section 4 hereof. Neither the failure of
the Corporation (including its board of directors or its stockholders) to have made a determination prior to the commencement of such enforcement action that indemnification of Agent is proper in the circumstances, nor an actual determination by the
Corporation (including its board of directors or its stockholders) that such indemnification is improper shall be a defense to the action or create a presumption that Agent is not entitled to indemnification under this Agreement or otherwise.

 12. Subrogation. In the event of payment under this Agreement, the Corporation shall be subrogated to the extent of
such payment to all of the rights of recovery of Agent, who shall execute all documents required and shall do all acts that may be necessary to secure such rights and to enable the Corporation effectively to bring suit to enforce such rights.

 13. Non-Exclusivity of Rights. The rights conferred on Agent by this Agreement shall not be exclusive of any other
right which Agent may have or hereafter acquire under any statute, provision of the Charter or Bylaws, agreement, vote of stockholders or directors, or otherwise, both as to action in Agent’s official capacity and as to action in another
capacity while holding office. 
 14. Survival of Rights. 

(a) The rights conferred on Agent by this Agreement shall continue after Agent has ceased to be a director, officer, employee or
other agent of the Corporation or to serve at the request of the Corporation as a director, officer, employee or other agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, and shall inure to the
benefit of Agent’s heirs, executors and administrators. 
 (b) The Corporation shall require any successor (whether
direct or indirect, by purchase, merger, consolidation or otherwise) to all or substantially all of the business or assets of the Corporation, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the
Corporation would be required to perform if no such succession had taken place. 
 15. Separability. Each of the
provisions of this Agreement is a separate and distinct agreement and independent of the others, so that if any provision hereof shall be held to be invalid or unenforceable for any reason, such invalidity or unenforceability shall not affect the
validity or enforceability of the other provisions hereof. Furthermore, if this Agreement shall be invalidated in its entirety on any ground, then the Corporation shall nevertheless indemnify Agent to the fullest extent provided by the Charter, the
Bylaws, the DGCL or any other applicable law. 
 16. Governing Law. This Agreement shall be governed by, and construed
and enforced in accordance with, the laws of the State of Delaware, without regard to its principles of conflicts of laws. The Corporation and Agent hereby irrevocably and unconditionally (i) agree that any action or proceeding arising out of
or in connection with this Agreement may be brought in the Delaware Court of Chancery, (ii) consent to submit to the jurisdiction of the Delaware Court of Chancery for purposes of any action or proceeding arising out of or in connection with
this Agreement, (iii) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court of Chancery, and (iv) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in
the Delaware Court of Chancery has been brought in an improper or inconvenient forum. 

  
 5 

 17. Amendment and Termination. No amendment, modification, termination or
cancellation of this Agreement shall be effective unless in writing signed by both parties hereto. 
 18. Identical
Counterparts. This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute but one and the same Agreement. Only one such counterpart need
be produced to evidence the existence of this Agreement. 
 19. Notices. All notices, requests, demands and other
communications hereunder shall be in writing and shall be deemed to have been duly given (i) upon delivery if delivered by hand to the party to whom such communication was directed or (ii) upon the third business day after the date on
which such communication was mailed if mailed by certified or registered mail with postage prepaid: 
  

	 	(a)	If to Agent, at the address indicated on the signature page hereof. 

 

	 	(b)	If to the Corporation, to: 

 Rib-X Pharmaceuticals, Inc. 
 300 George Street, Suite 301 

New Haven, CT 06511 
 Attention: Chief Executive Officer 
 or to such other address as may have been
furnished to Agent by the Corporation. 
 20. Headings. The headings of the sections of this Agreement are inserted for
convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction hereof. 
 [Remainder
of page intentionally left blank] 

  
 6 

 IN WITNESS WHEREOF, the parties hereto have executed this Indemnification Agreement
on and as of the day and year first above written. 
  

			
	RIB-X PHARMACEUTICALS, INC.
		
	By:	 	  

	Name:
	Title:
	
	AGENT
	
	  

	[Insert Name of Agent]
	
	Address:
	
	  

	  

  
 7Form of Restricted Stock Award Agreement

 Exhibit 10.1 
 HYATT HOTELS CORPORATION 
 Restricted Stock Award 

The following sets forth the terms of your Hyatt Hotels Corporation Restricted Stock (“Restricted Stock”) Award to you: 

 

					
	 AWARD:
	  		  	
			
		  	Shares:	  	            shares of Class A Common Stock of Hyatt Hotels Corporation
			
		  	 Restricted Stock

Grant Identifier:
	  	
	
	PERFORMANCE CONDITIONS:
			
		  	 Performance

Period:
	  	 [INSERT PERFORMANCE PERIOD]

			
		  	Vesting of Award and Payment Date:	  	Shares of Restricted Stock vest (or not) based on achievement relative to the Performance Goal set forth in this Agreement. To the extent that the Performance Goal is met, shares
of Restricted Stock shall vest and be paid to the Participant on the date that the Committee certifies that the Performance Goal is met, provided that the Participant remains in the employment or service of the Company through the last day of the
Performance Period (except for a termination of employment or service due to death, Disability or Retirement, or in the event of a Change in Control as provided below).

 The Restricted Stock Award that is described and made pursuant to this Restricted Stock Award (this
“Award”) is issued under the Amended and Restated Hyatt Hotels Corporation Long-Term Incentive Plan (as amended from time to time, the “Plan”). By electronically acknowledging and accepting this Award within 30 days
after the date of the electronic mail notification to you of the grant of this Award (the “Electronic Notification Date), you agree to be bound by the terms and conditions herein, the Plan and all conditions established by the Company in
connection with awards issued under the Plan. In order to vest in the Award you must accept this Award within 30 days of the Electronic Notification Date. If you fail to accept this Award within 30 days of the Electronic Notification Date, the Award
will be cancelled and forfeited. 

 The following terms and conditions apply to the Restricted Stock granted pursuant to this Award.

  

											
	 Company; Defined

Terms:
	  	Except as the context may otherwise require, references to the “Company” shall be deemed to include its subsidiaries and affiliates.
		
		  	To the extent not defined herein, capitalized terms shall have the meanings ascribed to them in the Plan.
		
	 Determination of

Number of Earned

Shares of Restricted

Stock:
	  	The number of shares of Restricted Stock that will vest, if any, shall be determined as follows:
		  	        Vested shares of Restricted Stock = Vested Percentage x Award
		
		  	The “Vested Percentage” is based on achievement with respect to [INSERT PERFORMANCE GOAL] (the “Performance Goal”) over the
Performance Period, determined at the end of the Performance Period, in accordance with the following table:

  

									
	 	  	Below
Threshold	 	Threshold	 	Target	 	Maximum
	 [INSERT PERFORMANCE GOAL]
	  		 		 		 	
	 Vested

Percentage
	  	0%	 	12.5%	 	50%	 	100%

  

			
		  	Achievement between threshold and target and between target and maximum will be interpolated linearly.
		
		  	All shares of Restricted Stock that are not vested at the end of the Performance Period shall be forfeited.
		
		  	The Committee shall have the sole authority and discretion to determine the achievement level of the Performance Goal and the number of shares of Restricted Stock earned at the end
of the Performance Period, including the discretion to adjust the actual achievement of the Performance Goal by the Company to reflect one or more of the following: (i) items related to a change in accounting principles; (ii) items relating to
financing activities; (iii) expenses for restructuring or productivity initiatives; (iv) other non-operating items; (v) items related to acquisitions; (vi) items attributable to the business operations of any entity acquired by the Company
during the Performance Period; (vii) items related to the disposal of a business or segment of a business; (viii) items attributable to any stock dividend, stock split, combination or exchange of stock occurring during the Performance Period;
(ix) any other items of significant income or expense which are determined to be appropriate adjustments; (x) items relating to unusual or extraordinary corporate transactions, events or developments; (xi) items relating to changes in tax
laws; (xii) items relating to major partnership arrangements; (xiii) items relating to gains or losses for litigation, arbitration and contractual settlements; or (xiv) items relating to any other unusual or

  
 2 

			
		  	nonrecurring events or changes in applicable laws, accounting principles or business conditions.
		
		  	The Restricted Stock shall vest on the date the Committee determines and certifies the attainment of the Performance Goal.
		
		  	[INSERT DEFINITION OF PERFORMANCE GOAL]

  
 3 

			
		
	 Termination of Service:
	 	 Subject to the exceptions below, vested Restricted Stock will be payable only if the Participant remains in continuous Service (as
defined below) with the Company from the Grant Date through the last day of the Performance Period. “Service” for purposes of this Award shall mean employment as an Employee, or service to the Company as a Director or Consultant.
Except as provided below, all unvested Restricted Stock will be forfeited and cancelled upon Termination of Service. Notwithstanding the foregoing, the ability to vest in the Restricted Stock will not be forfeited in the following
circumstances:
  

•         In the event of Termination of Service due to death
or Disability (as defined below), the Restricted Stock shall vest as if the Participant remained employed through the last day of the Performance Period. For this purpose “Disability” shall mean either (i) the Participant is unable
to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, (ii) the
Participant is by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months, receiving income replacement benefits for a
period of not less than three months under the Company’s long-term disability or other accident and health plan, or (iii) the Participant is determined to be totally disabled by the Social Security Administration.

 

•         Notwithstanding the Amended and Restated Retirement
Policy Regarding Equity Vesting adopted by Hyatt Hotels Corporation (the “Retirement Policy”), in the event of Retirement (as defined in the Retirement Policy) the number of shares of Restricted Stock that shall be vested at the end
of the Performance Period shall be determined on a pro rata basis in an amount equal to the total number of shares of Restricted Stock which would otherwise be vested at the end of the Performance Period multiplied by a fraction the numerator of
which is the number of full months elapsed in the Performance Period through the Participant’s

  
 4 

			
		  	 date of Retirement and the denominator of which is 36.

 
 As described below, shares of Restricted Stock are subject to cancellation and
forfeiture in the event the Participant engages in certain “detrimental conduct” (as defined below).

		
	Change in Control:	  	In the event of a Change in Control during the Performance Period, the Restricted Stock will be deemed to have been vested at the greater of (a) 50% of the shares of Restricted
Stock or (b) the number of shares of Restricted Stock that would be payable based on the actual performance of the Company determined as if the date of the Change in Control was the last day of the Performance Period. Once vested the Restricted
Stock will no longer be subject to forfeiture and cancellation under the terms of this Award. Any shares of Restricted Stock that are not vested upon a Change in Control shall be forfeited and cancelled.
		
	Rights of Ownership/Escrow	  	Subject only to the terms of this Agreement, the Participant shall have all rights as a stockholder in the shares of Restricted Stock. However, the shares of Restricted Stock
shall be held in escrow by the Company, and shall be released from escrow to the account of the Participant only upon vesting.
		
	Dividend Rights:	  	During the period beginning on the Grant Date and ending on the last day of the Performance Period if the Company pays a cash dividend on its Common Stock, such cash dividend
will be held in escrow by the Company and paid to the Participant when, and if, and to the extent that the Restricted Stock becomes vested.
		
	Tax Withholding:	  	 Unless paid in cash by the Participant at the time of settlement, the Company will deduct or withhold from shares issuable upon
vesting of the Restricted Stock a number of shares of Common Stock having a Share Value equal to the amount sufficient to satisfy the minimum statutory federal, state, foreign and local taxes and any employment, disability, social welfare or other
legally required withholdings. Notwithstanding anything to the contrary herein, if the tax obligation arises during period in which the Participant is prohibited from trading under any policy of the Company or by reason of the Securities Exchange
Act of 1934, then the tax withholding obligation shall automatically be satisfied by the Company withholding shares of Common Stock.
  

The Participant is encouraged to consult with a tax advisor regarding the tax consequences of participation in the Plan and acceptance of this
Award.

  
 5 

			
	Transferability of Restricted Stock:	  	Restricted Stock may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated unless and until the Restricted Stock has vested, and all other terms and
conditions set forth herein and in the Plan have been satisfied; provided that in the event of the Participant’s death, shares deliverable or amounts payable with respect to the Restricted Stock shall be delivered or paid, as applicable, to the
Participant’s designated beneficiary. The Administrator will advise Participants with respect to the procedures for naming and changing designated beneficiaries.
		
	Data Privacy: 	  	By acceptance of this Award, the Participant acknowledges and consents to the collection, use, processing and transfer of personal data as described below and in accordance with
the Hyatt Global Privacy Policy for Employees. The Company, its affiliates and the Participant’s employer hold certain personal information, including the Participant’s name, home address and telephone number, date of birth, social
security number or other employee tax identification number, salary, nationality, job title, and any equity compensation grants or Common Stock awarded, cancelled, purchased, vested, unvested or outstanding in the Participant’s favor, for the
purpose of managing and administering the Plan (“Data”). The Company and its affiliates will transfer Data to any third parties assisting the Company in the implementation, administration and management of the Plan. These recipients
may be located in the United States, the European Economic Area, or elsewhere. The Participant hereby authorizes them to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing,
administering and managing participation in the Plan, including any requisite transfer of such Data as may be required for the administration of the Plan on behalf of the Participant to a third party with whom the Participant may have elected to
have payment made pursuant to the Plan. The Participant may, at any time, review Data, require any necessary amendments to it or withdraw the consent herein in writing by contacting the Company; however, withdrawing the consent may affect the
Participant’s ability to participate in the Plan and receive the benefits intended by this Award.
		
	No Impact on Other Rights:	  	Participation in the Plan is voluntary. The value of the Restricted Stock is an extraordinary item of compensation outside the scope of Participant’s normal employment and
compensation rights, if any. As such, the Restricted Stock is not part of normal or expected compensation for purposes of calculating any severance, resignation, redundancy, end of service payments, bonuses, long-service awards, pensions or
retirement benefits or similar payments unless specifically and otherwise provided in the plans or agreements governing such compensation. The Plan is discretionary in nature and may be amended, cancelled, or terminated by the Company, in its sole
discretion, at any time. The grant of Restricted Stock under the Plan is a one-time benefit and does not create any contractual or other right to receive any other grant of Restricted Stock or other awards under the Plan in the future. Future
grants, if any, will be at the sole discretion of the Company, including, but not limited to, the timing of the grant, the form of award, number of shares of Common Stock subject to an award, vesting, and exercise provisions, as
relevant.

  
 6 

			
	 Effect of Detrimental
 Conduct:
	  	 In the event the Participant engages in “detrimental conduct” (as defined below), the Participant shall forfeit all unvested
shares of Restricted Stock and all such awards shall be null and void as of the date such detrimental conduct first occurs.
  
 Definition of Detrimental Conduct. The Participant will be deemed to have engaged in detrimental conduct if in the reasonable, good faith determination of the Administrator, the Participant has
engaged in conduct constituting (1) a felony; (2) gross negligence or willful misconduct in the performance of Participant’s duties and responsibilities to the Company; (3) willful violation of a material Company policy, including, without
limitation, any policy relating to confidentiality, honesty, integrity and/or workplace behavior, which violation has resulted or may reasonably be expected to result in harm to the Company, its stockholders, directors, officers, employees or
customers; (4) improper internal or external disclosure or use of confidential information or material concerning the Company or any of its stockholders, directors, officers, or employees which use or disclosure has resulted or may reasonably
be expected to result in harm to the Company; (5) publicly disparaging the Company or any of its stockholders, directors, officers or employees; and/or (6) willful violation of any material agreements with the Company entered into by the
Participant in connection with or pursuant to the Plan.
  
 Determination
of Detrimental Conduct. Upon a reasonable, good faith determination that detrimental conduct has occurred, the Administrator shall give the Participant written notice, which shall specify the conduct and the date of the conduct. Any dispute
concerning the matters set forth in the notice shall be decided under the procedures in the Plan.

 PARTICIPANT ACKNOWLEDGES AND AGREES THAT THE RESTRICTED STOCK AWARDED PURSUANT TO THIS AGREEMENT ARE EARNED ONLY BY
CONTINUING EMPLOYMENT AT THE WILL OF THE COMPANY (NOT THROUGH THE ACT OF BEING HIRED, BEING GRANTED THIS AWARD OR ACQUIRING SHARES HEREUNDER) AND BY ACHIEVEMENT OF THE PERFORMANCE GOAL AND BY COMPLIANCE WITH PARTICIPANT’S VARIOUS OBLIGATIONS
UNDER THIS AGREEMENT. PARTICIPANT FURTHER ACKNOWLEDGES AND AGREES THAT NOTHING IN THIS AGREEMENT, NOR IN THE PLAN SHALL CONFER UPON PARTICIPANT ANY RIGHT WITH RESPECT TO CONTINUATION OF EMPLOYMENT BY THE COMPANY, NOR SHALL IT INTERFERE IN ANY WAY
WITH PARTICIPANT’S RIGHT OR THE COMPANY’S RIGHT TO TERMINATE PARTICIPANT’S EMPLOYMENT AT ANY TIME, FOR ANY REASON OR NO REASON, WITH OR WITHOUT CAUSE, AND WITH OR WITHOUT ADVANCE NOTICE EXCEPT AS MAY BE REQUIRED BY APPLICABLE LAW.

  
 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00202-of-00352.parquet"}]]